Kerala Ayurveda Quarterly Results for Trading Insights
KERALAYUR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-6 Cr
QSept 2025
Kerala Ayurveda Quarterly Results Key Highlights
- Revenue of ₹37 Cr in Sept 2025 (+15.6% vs Mar 2025, +19.4% vs Sept 2024)
- Net Profit of ₹-6 Cr in Sept 2025 (+60.0% vs Mar 2025, -250.0% vs Sept 2024)
- EBITDA of ₹-3 Cr in Sept 2025 (+66.7% vs Mar 2025)
- Operating Margin of -14.0% in Sept 2025 (+18.0pp vs Mar 2025)
- Earnings Per Share of ₹-7.23 in Sept 2025 (+47.1% vs Mar 2025)
Kerala Ayurveda Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 37 | 32 | 38 | 31 | 32 | 15.6% | 19.4% |
| Net Profit (₹ Cr) | -6 | -15 | 2 | 4 | 1 | - | - |
| EBITDA (₹ Cr) | -3 | -9 | 5 | 6 | 5 | - | - |
| EPS (₹) | -7.23 | -13.68 | 1.92 | 3.10 | 0.50 | - | - |
| Operating Margin (%) | -14.0% | -32.0% | -15.0% | 18.0% | 15.0% | - | - |
Kerala Ayurveda Share Price Trend Around Quarterly Results
Visualize Kerala Ayurveda's 1-year price movement across quarterly results — ideal for logging trades in Kerala Ayurveda share price
chart using Tickjournal. All values in ₹.
Related Pages for Kerala Ayurveda
Additional stock information and data for KERALAYUR
Revenue Trend (₹ Cr)
Sept 2024
31
Jun 2025
38
Mar 2025
32
Sept 2025
37
Net Profit Trend (₹ Cr)
Sept 2024
4
Jun 2025
2
Mar 2025
-15
Sept 2025
-6
Operating Margin Trend (%)
Sept 2024
18.0%
Jun 2025
-15.0%
Mar 2025
-32.0%
Sept 2025
-14.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Kerala Ayurveda quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores